Clinical Trial Update: Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetic interaction between nevirapine and saquinavir-sgc in HIV-1 infected patients; the trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Viramune (Nevirapine)
• saquinavir-sgc (saquinavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 1 | Status: TERMINATED